Owner
U
UntitledVerification
Tags
π TABLE 1 β Drugs with VERY HIGH Oral Bioavailability (β90β100%)
(Minimal first-pass effect + near-complete absorption)
Category | Drugs |
Antibiotics | Metronidazole, Linezolid, Chloramphenicol, Doxycycline, Minocycline, Clindamycin |
Antifungals | Fluconazole, Voriconazole |
CNS β Benzodiazepines | Diazepam, Lorazepam, Alprazolam, Clonazepam |
Antiepileptics | Levetiracetam, Valproate, Lamotrigine |
Anticoagulant | Warfarin |
Analgesic | Paracetamol |
Respiratory | Theophylline, Montelukast |
Miscellaneous (High-yield) | Allopurinol, Pregabalin, Gabapentin, Methyldopa, Clonidine |
π Exam note: These have high / near-complete oral bioavailability, but examiners usually avoid saying βabsolute 100%β.
π TABLE 2 β Drugs with <100% Oral Bioavailability (EXAM TRAPS)
Reason | Drug examples | Key exam logic |
Extensive first-pass hepatic metabolism | Propranolol, Metoprolol, Verapamil, Morphine, Lidocaine | Large fraction metabolised before reaching systemic circulation |
Incomplete / variable absorption | Digoxin, Furosemide, Acyclovir | Poor solubility or permeability |
P-glycoprotein efflux | Digoxin, Cyclosporine, Rivaroxaban | Drug pumped back into gut lumen |
Degradation in stomach / intestine | Penicillin G, Erythromycin (base), Insulin | Acid or enzymatic destruction |
Food interaction reduces absorption | Levothyroxine, Alendronate, Tetracyclines | Chelation or binding with food |
Presystemic gut wall metabolism (CYP3A4) | Midazolam, Cyclosporine | Intestinal metabolism before liver |
High polarity / large molecule | Heparin, LMWH | Cannot cross intestinal epithelium |
Chemical instability | Nitroglycerin | Rapid degradation β very low oral BA |